A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Investigate the Efficacy and Safety of VEC-162 [tasimelteon] and Matching Placebo in Healthy Male and Female Subjects With Induced Transient Insomnia

Trial Profile

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Investigate the Efficacy and Safety of VEC-162 [tasimelteon] and Matching Placebo in Healthy Male and Female Subjects With Induced Transient Insomnia

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Nov 2014

At a glance

  • Drugs Tasimelteon (Primary)
  • Indications Insomnia
  • Focus Registrational; Therapeutic Use
  • Sponsors Vanda Pharmaceuticals
  • Most Recent Events

    • 20 May 2009 Results presented at APA 2009.
    • 02 Dec 2008 Results published in the Lancet.
    • 17 Nov 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top